About: Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Safety Study of AVP-923 in the Treatment of IEED (nl) Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) (en)
skos:prefLabel	Safety Study of AVP-923 in the Treatment of IEED (nl) Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) (en)
name	Safety Study of AVP-923 in the Treatment of IEED (nl) Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) (en)
title	wds:Q66037071-AD3C8618-4BFA-4BE2-8B50-66EBBA68B8E0
title	An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect. (en)
end time	wds:Q66037071-AE893385-04D8-4D4D-AF9E-098AAA9E24F1
end time	2007-06-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q66037071-1A90BBC0-A982-4778-88CE-FB4A1CC80A2B
instance of	clinical trial
start time	wds:Q66037071-63FF8965-F069-446D-97E0-57F187E97937
start time	2003-02-01 00:00:00Z (xsd:dateTime)
country	wds:Q66037071-6F7A968B-5CB7-48A0-B1AA-87847C79B124
country	United States of America
research site	wds:Q66037071-035FF67F-7191-49E4-B7B1-A53B27C5A2D8 wds:Q66037071-0F406728-A8C4-4B39-A702-466371FF1419 wds:Q66037071-44464DD2-BBAF-4654-9E00-4850933A6DF8 wds:Q66037071-500F9441-54A2-4616-872B-7C9CB69F935A wds:Q66037071-8F39F128-1B7E-4DA6-B7A6-78194C426D29 wds:Q66037071-97C09129-9B47-4AA6-B71C-ADADDAA8CB5D wds:Q66037071-A3189017-4697-42CC-9CA3-468E3C9E5076
research site	University of Wisconsin–Madison University at Buffalo Carolinas Medical Center Barrow Neurological Institute MetroHealth Medical Center Advanced Neurology Specialists AMC Neurology Group Clinical Research Center
minimum age	wds:Q66037071-70EE88F5-EEE4-4C7A-AE5E-D6993B1A550E
minimum age	18 (xsd:decimal)
medical condition	wds:Q66037071-5D65A9BF-1E51-42D0-A268-483705C35523
medical condition	Parkinson's disease
number of participants	wds:Q66037071-920DD465-3BB5-436E-8F23-429F74BC4CDF
number of participants	600 (xsd:decimal)
maximum age	wds:Q66037071-B5B565A5-0E26-4573-8B3F-0E9C28392943
maximum age	80 (xsd:decimal)
study type	wds:Q66037071-0AFC2526-57F2-48F7-9589-8B54F2E78DE6
study type	interventional study
ClinicalTrials.gov ID	wds:Q66037071-E43FDFCF-C352-4032-A4FA-51C88812E6B6
ClinicalTrials.gov ID	NCT00056524
clinical trial phase	wds:Q66037071-BAB9EBD2-CFDF-4292-B589-AACBAE1AF542
clinical trial phase	phase III clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q66037071

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software